Tissue and Bronchoalveolar Lavage Biomarkers in Idiopathic Pulmonary Fibrosis Patients on Pirfenidone.

Nicola RonanDeirdre M BennettKashif A KhanYvonne McCarthyDarren DahlyLouise BourkeAdeline ChelliahAlberto CavazzaKevin O'ReganFiachra MoloneyBarry J PlantMichael T Henry

Published in: Lung (2018)

TBLC offers a unique opportunity to potentially assess the course of disease activity and response to novel anti-fibrotic activity in IPF.

Keyphrases

idiopathic pulmonary fibrosis
disease activity
interstitial lung disease
rheumatoid arthritis
systemic lupus erythematosus
end stage renal disease
rheumatoid arthritis patients
ejection fraction
ankylosing spondylitis
chronic kidney disease
juvenile idiopathic arthritis
prognostic factors
systemic sclerosis